Cargando…
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
The known seven mammalian receptor subunits (P2X1–7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization al...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199792/ https://www.ncbi.nlm.nih.gov/pubmed/33125712 http://dx.doi.org/10.1111/bph.15299 |
_version_ | 1783707460956061696 |
---|---|
author | Illes, Peter Müller, Christa E. Jacobson, Kenneth A. Grutter, Thomas Nicke, Annette Fountain, Samuel J. Kennedy, Charles Schmalzing, Günther Jarvis, Michael F. Stojilkovic, Stanko S. King, Brian F. Virgilio, Francesco Di |
author_facet | Illes, Peter Müller, Christa E. Jacobson, Kenneth A. Grutter, Thomas Nicke, Annette Fountain, Samuel J. Kennedy, Charles Schmalzing, Günther Jarvis, Michael F. Stojilkovic, Stanko S. King, Brian F. Virgilio, Francesco Di |
author_sort | Illes, Peter |
collection | PubMed |
description | The known seven mammalian receptor subunits (P2X1–7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization allowed the identification of the 3D structure and gating cycle of P2X receptors. The agonist-binding pocket is located at the intersection of two neighbouring subunits. In addition to the mammalian P2X receptors, their primitive ligand-gated counterparts with little structural similarity have also been cloned. Selective agonists for P2X receptor subtypes are not available, but medicinal chemistry supplied a range of subtype-selective antagonists, as well as positive and negative allosteric modulators. Knockout mice and selective antagonists helped to identify pathological functions due to defective P2X receptors, such as male infertility (P2X1), hearing loss (P2X2), pain/cough (P2X3), neuropathic pain (P2X4), inflammatory bone loss (P2X5), and faulty immune reactions (P2X7). |
format | Online Article Text |
id | pubmed-8199792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-81997922022-02-01 Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 Illes, Peter Müller, Christa E. Jacobson, Kenneth A. Grutter, Thomas Nicke, Annette Fountain, Samuel J. Kennedy, Charles Schmalzing, Günther Jarvis, Michael F. Stojilkovic, Stanko S. King, Brian F. Virgilio, Francesco Di Br J Pharmacol Article The known seven mammalian receptor subunits (P2X1–7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization allowed the identification of the 3D structure and gating cycle of P2X receptors. The agonist-binding pocket is located at the intersection of two neighbouring subunits. In addition to the mammalian P2X receptors, their primitive ligand-gated counterparts with little structural similarity have also been cloned. Selective agonists for P2X receptor subtypes are not available, but medicinal chemistry supplied a range of subtype-selective antagonists, as well as positive and negative allosteric modulators. Knockout mice and selective antagonists helped to identify pathological functions due to defective P2X receptors, such as male infertility (P2X1), hearing loss (P2X2), pain/cough (P2X3), neuropathic pain (P2X4), inflammatory bone loss (P2X5), and faulty immune reactions (P2X7). 2020-12-21 2021-02 /pmc/articles/PMC8199792/ /pubmed/33125712 http://dx.doi.org/10.1111/bph.15299 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Illes, Peter Müller, Christa E. Jacobson, Kenneth A. Grutter, Thomas Nicke, Annette Fountain, Samuel J. Kennedy, Charles Schmalzing, Günther Jarvis, Michael F. Stojilkovic, Stanko S. King, Brian F. Virgilio, Francesco Di Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title_full | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title_fullStr | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title_full_unstemmed | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title_short | Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 |
title_sort | update of p2x receptor properties and their pharmacology: iuphar review 30 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199792/ https://www.ncbi.nlm.nih.gov/pubmed/33125712 http://dx.doi.org/10.1111/bph.15299 |
work_keys_str_mv | AT illespeter updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT mullerchristae updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT jacobsonkennetha updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT grutterthomas updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT nickeannette updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT fountainsamuelj updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT kennedycharles updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT schmalzinggunther updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT jarvismichaelf updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT stojilkovicstankos updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT kingbrianf updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 AT virgiliofrancescodi updateofp2xreceptorpropertiesandtheirpharmacologyiupharreview30 |